drugset

drugset / Trial / NCT01055912

Study to Evaluate the Effects of Oral Administration of Lixivaptan in Patients With Congestive Heart Failure

NCT01055912 ↗

Phase 2 Completed 170 enrolled CardioKine Inc. Cardiokine Biopharma, LLC · collab

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the effects of oral lixivaptan capsules in patients with congestive heart failure.

Timeline

Start: 2010-01
Primary completion: 2010-09
Completion: —

Publications

Ghali JK, Orlandi C, Abraham WT; CK-LX2401 Study Investigators. The efficacy and safety of lixivaptan in outpatients with heart failure and volume overload: results of a multicentre, randomized, double-blind, placebo-controlled, parallel-group study. Eur J Heart Fail. 2012 Jun;14(6):642-51. doi: 10.1093/eurjhf/hfs051. Epub 2012 Apr 17.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lixivaptan	Small molecule	100 mg	Oral

Indications